VXRT News and Press, Vaxart Inc. From 03/31/23

2023-03-31 15:00:41 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...

SOUTH SAN FRANCISCO, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will make presentations at the World Vaccine Congress Washington 2023 in Washin...

Company to provide a detailed overview of its norovirus clinical program Webcast to be held on March 28, 2023 at 1:00 p.m. ET SOUTH SAN FRANCISCO, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will host a key opinion leader video webcast...

2023-03-15 20:51:01 ET Vaxart, Inc. (VXRT) Q4 2022 Earnings Conference Call March 15, 2023 04:30 PM ET Company Participants Brant Biehn - Senior Vice President, Business Operations Andrei Floroiu - Chief Executive Officer James Cummings - Chief Medical Officer ...

2023-03-15 16:33:16 ET Issuing its Q4 2022 financials on Wednesday, vaccine developer Vaxart ( NASDAQ: VXRT ) announced a portfolio reorganization to prioritize its oral norovirus vaccine program and postpone further COVID-19 clinical trials. The decision, which also inv...

2023-03-15 16:02:16 ET Vaxart press release ( NASDAQ: VXRT ): FY GAAP EPS of -$0.84 misses by $0.01 . Vaxart ended the year with cash, cash equivalents, restricted cash and marketable securities of $95.7 million. Vaxart expects its cash on hand will extend into Q2 ...

Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development Will continue preclinical development of novel COVID-19 vaccine constructs to enhance cross-reactivity and potency with the goal of developing a pan-betacoronavirus vaccine ...

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the full year ended December 31, 2022 after the market close on Wednes...

Study to evaluate safety and immunogenicity of oral norovirus vaccine in healthy adults SOUTH SAN FRANCISCO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that it has dosed the first subject in the Phase 2 clinical trial of its oral tablet bivalent ...

The new year is rapidly approaching, which means figuring out how to make money in the stock market. One of the asset classes that has continued outperforming broader markets daily has been stocks under $5. Known as penny stocks , these cheap shares are well-known for their short-term yet...